NOVEL IMIDAZOLE QUINOLINE-BASED IMMUNE SYSTEM MODULATORS
摘要
The present invention relates to a compound of Formula I: or an enantiomer, diastereomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same.
申请公布号
EP2763677(A4)
申请公布日期
2015.05.20
申请号
EP20120837804
申请日期
2012.10.03
申请人
JANUS BIOTHERAPEUTICS, INC.;LIPFORD, GRAYSON, B.;ZEPP, CHARLES, M.